Bavarian Nordic A/S (BAVA.CO)

BAVA.CO

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines within biodefence, cancer and infectious diseases therapeutic areas. The Company operates within two segments: Cancer Vaccines and Infectious Disease. The Cancer Vaccines’ pipeline is focused on... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.68
Market Cap (Mil.):	kr.1,748.32
Shares Outstanding (Mil.):	26.09
Dividend:	--
Yield (%):	--

Financials

	BAVA.CO	Industry	Sector
P/E (TTM):	--	27.85	34.30
EPS (TTM):	-9.20	--	--
ROI:	-20.28	7.01	18.43
ROE:	-21.75	11.53	19.30

Latest News about BAVA.CO

BRIEF-Bavarian Nordic to shift vaccine work to Denmark from Germany

Jan 11 - Bavarian Nordic A/S says: * consolidates its vaccine manufacturing in Denmark * to prepare its Kvistgaard facility for the future commercial production of its prostate cancer vaccine, Prostvac, and transfer its production of clinical trial material to the facility. * to close its operations in Berlin, Germany where it has been producing clinical trial material for its MVA-BN based vaccine candidates * planned changes do not affect company expectations for 2012 full year re

11 Jan 2013

» More BAVA.CO News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Bavarian Nordic A/S (BAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
Bavarian Nordic A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Wright Investors Service Comprehensive Report for Bavarian Nordic AS Provider: Wright Reports	$472.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.